Nebivolol
Therapeutic agent (verify pharmacological class)
What it is used for
Therapeutic use is agent- and indication-specific within the class (Therapeutic agent (verify pharmacological class)). Use according to culture results, national guidelines (Kenya STG/EML where applicable) and the current product SmPC. Hypertension, CHF
Warnings
Deterioration of renal function, allergic reactions, bradycardia, chest pain, dizziness, dyspnea, edema, hypotension, weight increase, syncope, fever, haematuria, hepatic injury, depression, mental, thrombocytopenia.
Possible side effects
Bradycardia; headache; oedema; dizziness; insomnia; hypercholesterolaemia; lowered HDL levels; hyperuricaemia; raised triglyceride levels; diarrhoea; nausea; abdominal pain; thrombocytopenia; paraesthesia.
Storage
Store as labelled. Keep out of reach of children.
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.